Vir Biotechnology, Inc. (NASDAQ:VIR) has 214 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 16,330,103 | 362,447 | 2.27% | $98,470,521.00 |
| SB INVESTMENT ADVISERS (UK) LTD | 31 Dec, 2025 | 13,116,977 | -3,567,064 | -21.38% | $79,095,371.00 |
| ARCH Venture Management, LLC | 31 Dec, 2025 | 12,916,663 | 0 | 0.00% | $77,887,478.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 12,548,944 | -250,437 | -1.96% | $75,670,133.00 |
| GSK plc | 31 Dec, 2025 | 8,550,954 | 8,550,954 | 0.00% | $51,562,253.00 |
| State Street Corp | 31 Dec, 2025 | 6,229,555 | 988,262 | 18.86% | $37,564,217.00 |
| FMR LLC | 31 Dec, 2025 | 3,158,416 | -478,714 | -13.16% | $19,045,246.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 3,137,808 | 1,616,006 | 106.19% | $18,920,982.00 |
| Morgan Stanley | 31 Dec, 2025 | 2,679,145 | -9,973 | -0.37% | $16,155,254.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 2,536,277 | -442,594 | -14.86% | $15,292,107.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 2,380,715 | 0 | 0.00% | $14,355,711.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,328,207 | 81,985 | 3.65% | $14,041,408.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 1,390,577 | -135,688 | -8.89% | $8,385,179.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 1,368,474 | 1,368,474 | 0.00% | $8,251,898.00 |
| Hudson Bay Capital Management LP | 31 Dec, 2025 | 1,325,000 | -498,764 | -27.35% | $7,989,750.00 |
| Candriam S.C.A. | 31 Dec, 2025 | 1,031,663 | 1,031,663 | 0.00% | $6,221,193.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 1,002,606 | -393,898 | -28.21% | $6,045,714.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 930,908 | 128,942 | 16.08% | $5,613,376.00 |
| GordonMD Global Investments LP | 31 Dec, 2025 | 930,317 | 930,317 | 0.00% | $5,609,812.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 904,480 | -238,399 | -20.86% | $5,454,014.00 |